Pharma industry bodies have already raised the issue with the government, sending an emergency report highlighting the risk to raw material supplies.
The ongoing Iran–Israel–US conflict is beginning to affect India’s medicine supply, raising concerns over a possible rise in prices in the coming weeks. Traders and industry representatives say the impact is already visible at the wholesale level.
At Bhagirathi Palace Market in Delhi, one of the country’s key wholesale hubs for medicines, traders say the pressure is building. Ashish Grover, president of the Delhi Drug Traders Association, said rising input costs are starting to affect the entire supply chain.
